James Chrabaszcz
Nurse Practitioner · Elmira, NYNPI 1487705703
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 460 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,657 and has fallen 97.7% since, to $61 in 2024. Among nurse practitioner clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 460 payments — averaging $16.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Regeneron Healthcare Solutions, Inc.$335
- Ardelyx, Inc.$316
- plus $1K from 13 others
What the payments were for
- Food & beverage$7,11096%
- Education$3084%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 114 | $1,612 |
| AbbVie | 91 | $1,439 |
| Takeda Pharmaceuticals U.S.A., Inc. | 63 | $1,282 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 84 | $1,026 |
| Regeneron Healthcare Solutions, Inc. | 11 | $335 |
| Ardelyx, Inc. | 13 | $316 |
| QOL Medical, LLC | 19 | $310 |
| Bristol Myers Squibb | 21 | $303 |
| Intercept Pharmaceuticals, Inc. | 10 | $175 |
| Braintree Laboratories, Inc. | 10 | $167 |
| Pfizer | 5 | $111 |
| Boehringer Ingelheim | 4 | $76 |
| Organon | 3 | $58 |
| Gilead | 3 | $49 |
| Ferring Pharmaceuticals Inc. | 3 | $45 |
| Redhill Biopharma Inc. | 2 | $41 |
| Nestle Healthcare Nutrition Inc. | 2 | $30 |
| Sandoz | 1 | $25 |
| Amgen | 1 | $18 |
How this compares
$7,418 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 33 | $563 |
| Omeprazole | 24 | $346 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Elmira
- Patricia McGoldrickNew York$202K
- Michelle DartSyracuse$95K
- Susan KreppelWilliamsville$67K
- Kerry AhernEast Syracuse$55K
- Valerie StanleyAlbany$55K
- Jodi LogerfoNew York$48K
- Grace WlasowiczRochester$41K
- Melissa LevinElmhurst$34K
- Carla JungquistCanandaigua$28K
- Kelly WilmarthJohnson City$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.